Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239

Detalles Bibliográficos
Autores principales: Daitch, Vered, Paul, Mical, Leibovici, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739034/
https://www.ncbi.nlm.nih.gov/pubmed/36498604
http://dx.doi.org/10.3390/jcm11237029
_version_ 1784847700499365888
author Daitch, Vered
Paul, Mical
Leibovici, Leonard
author_facet Daitch, Vered
Paul, Mical
Leibovici, Leonard
author_sort Daitch, Vered
collection PubMed
description
format Online
Article
Text
id pubmed-9739034
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97390342022-12-11 Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239 Daitch, Vered Paul, Mical Leibovici, Leonard J Clin Med Comment MDPI 2022-11-28 /pmc/articles/PMC9739034/ /pubmed/36498604 http://dx.doi.org/10.3390/jcm11237029 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Daitch, Vered
Paul, Mical
Leibovici, Leonard
Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
title Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
title_full Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
title_fullStr Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
title_full_unstemmed Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
title_short Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
title_sort comment on huang et al. colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrug-resistant acinetobacter baumannii infection: a meta-analysis. j. clin. med. 2022, 11, 3239
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739034/
https://www.ncbi.nlm.nih.gov/pubmed/36498604
http://dx.doi.org/10.3390/jcm11237029
work_keys_str_mv AT daitchvered commentonhuangetalcolistinmonotherapyversuscolistinplusmeropenemcombinationtherapyforthetreatmentofmultidrugresistantacinetobacterbaumanniiinfectionametaanalysisjclinmed2022113239
AT paulmical commentonhuangetalcolistinmonotherapyversuscolistinplusmeropenemcombinationtherapyforthetreatmentofmultidrugresistantacinetobacterbaumanniiinfectionametaanalysisjclinmed2022113239
AT leibovicileonard commentonhuangetalcolistinmonotherapyversuscolistinplusmeropenemcombinationtherapyforthetreatmentofmultidrugresistantacinetobacterbaumanniiinfectionametaanalysisjclinmed2022113239

Ejemplares similares